, Singapore

DBS not alarmed by GDP plunge for 3Q10

 The bank said the 18%QoQ saar (10.8% YoY) GDP dip for the quarter is an upward revision from the advance estimates (-19.8% QoQ saar, 10.3% YoY) given the better than expected industrial production growth in September.


In a statement, DBS Bank said the rebound in pharmaceutical production caused the output in the month rose by a solid 26.2% YoY. This will put average manufacturing growth for the quarter at 14.6% YoY, which is higher than the 12.1% expansion noted in the advance estimates.


With the pharmaceutical output having fallen by 45.0% QoQ saar in the third quarter, the most likely direction in the next quarter should be up. “One quarter of down swing will soon be followed by a quarter of rebound as producers embark on new batches of drugs and ramp up production. As such, we believe a turnaround in pharmaceutical production could provide some lift to headline GDP growth in the fourth quarter,” the bank said.


 

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.


If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.